A Phase II Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme.
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2012
At a glance
- Drugs Bevacizumab; Temsirolimus
- Indications Glioblastoma
- Focus Biomarker; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 01 Jun 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 01 Jun 2010 Actual end date (February 2010) added as reported by ClinicalTrials.gov.